article thumbnail

Research: Business School Really Does Influence How Students Make Decisions Later On

Harvard Business Review

corporations from 1985 to 2015. As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. firms, and put the brakes on diversification.

article thumbnail

The Globalization Backlash Is Reverberating Through Boardrooms

Harvard Business Review

In 2015, Global Trade Alert, an independent trade-monitoring group, cited at least 644 discriminatory trade measures imposed by the G20 economies with the U.S. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Right Way to Use Analytics Isn’t for Planning

Harvard Business Review

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. Laura Schneider for HBR. The failures continue.

article thumbnail

What to Know About Doing Business in Iran

Harvard Business Review

sanctions are delaying these projects being financed. French automaker Renault has taken advantage of sanctions relief, assembling nearly 15,000 cars between January and April, a sevenfold increase from the same period in 2015. However, remaining U.S. financial system for bank transactions related to Iran.

article thumbnail

Many CEOs Aren’t Breakthrough Innovators (and That’s OK)

Harvard Business Review

We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Pharmaceuticals. The data captured a 20-year period, from 1995 to 2014. Overall, it is a messy picture.

CEO 8
article thumbnail

80% of Companies Don’t Know If Their Products Contain Conflict Minerals

Harvard Business Review

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

article thumbnail

7 Charts Show How Political Affiliation Shapes U.S. Boards

Harvard Business Review

Both Republicans and Democrats say the most effective board committee is audit/finance. For this analysis, we focused on responses from about 1,000 board members of companies headquartered in the United States that were submitted between October 2015 and December 2015.